Established 1999
123jump.com - U.S. Financial Information Archive: 90,000 Annual and 10-K reports – 20,000 Global news stories - 3,500 IPO reports - 1,700 - Earnings Calls – 320 Fund Interviews – 10-year Annual earnings on 4,500 stocks – 20 Quarterly earnings on 3,600 stocks – 1,800 IPO prospectuses – 1,200 Economic data releases
     
   
 
IPO Outlook: 
TechTarget IPO Rises at Start
Author: Yordanka Bahchevanska
123jump.com
Last Update: 3:46 PM EDT May 23 2007


As much as eleven new IPOs were launched during the past busy week for the IPO market. Insulet shares rose on their first day of trading Tuesday but traded flat at the end of the week. One of the week’s most anticipated IPOs, TechTarget, rose 14% from its offering price at the closing bell on Thursday. Ninety five IPOs have been priced so far in 2007 and 68% of them are trading above their offering price.

 
Ninety five initial public offerings have been priced so far this year as of May 18th, 2007:

- 65 IPOs are currently trading above initial offering price;
- 28 are trading below the offering price;
- and 2 are trading at their offer price.

Eleven IPOs were priced during the week of May 14th, 2007. There are seven deals on deck for the next week, hoping to raise nearly $1.5 billion.

IPO PERFORMANCE

ADVANCERS:

Insulet Corporation (PODD: chart) priced its initial public offering of 7.7 million shares of common stock at $15 per share, at the midpoint of the expected price range of $14 to $16.

The shares sold into the offer were 1 million more than initially set.

All shares in the offering are being sold by Insulet.

J.P. Morgan, Merrill Lynch, Pierce, Fenner & Smith managed the deal.

The company has granted the underwriters an option to purchase up to 1.15 million additional shares to cover over-allotments, if any.

The Bedford, Massachusetts-based medical device company has developed a U.S. Food and Drug Administration-approved insulin delivery system for people with insulin-dependent diabetes.

Insulet''s offering comes a few days after that of Biodel Inc. (BIOD: chart), which specializes in treatments for diabetes and osteoporosis. Biodel''s shares jumped 20% on their first day of trading.

The shares ended the week at $15.05 each, almost at its offering price.

Skilled Healthcare Group, Inc. (SKH: chart) on Monday priced its initial public offering of 19.2 million shares at $15.5 per share, compared with a $14 to $16 forecast.

The company sold 8.3 million shares in the offering, and selling stockholders sold the remaining 10.8 million shares. The deal was worth $258 million.

Credit Suisse Securities, UBS Investment and Banc of America acted as lead underwriters for the offering.

The underwriters have the option to purchase 2.5 million additional shares from selling shareholders to cover overallotments.

Skilled''s largest shareholder Onex Corp. (OCX: chart) will hold a 77.9% stake after the IPO, or 74.6% if the underwriters'' overallotment option is exercised in full.

Based in Foothill Ranch, California, the company runs more than 70 nursing homes and assisted-living facilities in five states, including California and Texas.

Shares of the company ended the week at $15.45 a share, up 2% from the offering price.

Shares of the China-based solar cell maker China Sunergy Co. (CSUN: chart) rose on their first day of trading Thursday after the company priced its initial public offering above the expected range of $8 to $10 a share, due to strong investors’ demand.

The offering of 8.5 million American depositary shares was priced at $11 each. One ADS represented six ordinary shares.
  1  2  3  4

 



 
© 1999-2008 123jump.com. All rights reserved